These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 33417509)
1. Second generation drug-eluting stents: a focus on safety and efficacy of current devices. Spione F; Brugaletta S Expert Rev Cardiovasc Ther; 2021 Feb; 19(2):107-127. PubMed ID: 33417509 [No Abstract] [Full Text] [Related]
3. From biodegradable polymers to bioresorbable vascular scaffolds: available evidence in the era of new-generation drug-eluting stents. Magliulo F; Piccolo R; Franzone A; Esposito G; Danzi GB Minerva Cardioangiol; 2018 Jun; 66(3):246-261. PubMed ID: 29160048 [TBL] [Abstract][Full Text] [Related]
4. Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single-blind, prospective, randomised superiority trial. Iglesias JF; Muller O; Heg D; Roffi M; Kurz DJ; Moarof I; Weilenmann D; Kaiser C; Tapponnier M; Stortecky S; Losdat S; Eeckhout E; Valgimigli M; Odutayo A; Zwahlen M; Jüni P; Windecker S; Pilgrim T Lancet; 2019 Oct; 394(10205):1243-1253. PubMed ID: 31488372 [TBL] [Abstract][Full Text] [Related]
5. Five-Year Outcomes of Biodegradable Polymer Drug-Eluting Stents Versus Second-Generation Durable Polymer Drug-Eluting Stents: a Meta-Analysis of Randomized Controlled Trials. Lou Y; Yu Y; Xi Z; Gao Y; Liu W; Nie X Cardiovasc Drugs Ther; 2019 Oct; 33(5):557-566. PubMed ID: 31773343 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of the MiStent sustained sirolimus eluting biodegradable polymer coated stent for the treatment of coronary artery disease: does uniform sustained abluminal drug release result in earlier strut coverage and better safety profile? Tijssen RYG; Kraak RP; Lu H; Mifek JG; Carlyle WC; Donohoe DJ; De Winter RJ; Koch KT; Wykrzykowska JJ Expert Rev Med Devices; 2017 May; 14(5):325-334. PubMed ID: 28402204 [TBL] [Abstract][Full Text] [Related]
7. Comparison of Durable-Polymer Zotarolimus-Eluting and Biodegradable-Polymer Biolimus-Eluting Coronary Stents in Patients With Coronary Artery Disease: 3-Year Clinical Outcomes in the Randomized SORT OUT VI Trial. Raungaard B; Christiansen EH; Bøtker HE; Hansen HS; Ravkilde J; Thuesen L; Aarøe J; Villadsen AB; Terkelsen CJ; Krusell LR; Maeng M; Kristensen SD; Veien KT; Hansen KN; Junker A; Madsen M; Andersen SL; Jensen SE; Jensen LO; JACC Cardiovasc Interv; 2017 Feb; 10(3):255-264. PubMed ID: 28109874 [TBL] [Abstract][Full Text] [Related]
8. Orsiro cobalt-chromium sirolimus-eluting stent: present and future perspectives. Iglesias JF; Roffi M; Degrauwe S; Secco GG; Aminian A; Windecker S; Pilgrim T Expert Rev Med Devices; 2017 Oct; 14(10):773-788. PubMed ID: 28889769 [TBL] [Abstract][Full Text] [Related]
9. A propensity score-matched comparison of biodegradable polymer vs second-generation durable polymer drug-eluting stents in a real-world population. Zhao YJ; Teng M; Khoo AL; Ananthakrishna R; Yeo TC; Lim BP; Loh JP; Chan MY Cardiovasc Ther; 2018 Apr; 36(2):. PubMed ID: 29316284 [TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer drug-eluting stents: a meta-analysis of randomized trials. Zhu P; Zhou X; Zhang C; Li H; Zhang Z; Song Z BMC Cardiovasc Disord; 2018 Aug; 18(1):170. PubMed ID: 30111289 [TBL] [Abstract][Full Text] [Related]
11. Stent Polymers: Do They Make a Difference? Rizas KD; Mehilli J Circ Cardiovasc Interv; 2016 Jun; 9(6):. PubMed ID: 27193905 [TBL] [Abstract][Full Text] [Related]
12. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial. Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698 [TBL] [Abstract][Full Text] [Related]